4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-054094
Director sold 50,489 shares at an average $29.24 ($1,476,135)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GADICKE ANSBERT Director | 2021-08-27 | Sale | −1,846 | $29.09 | $53,700 | 264,437 | D |
| GADICKE ANSBERT Director | 2021-08-27 | Sale | −13,357 | $29.09 | $388,555 | 7,792,126 | I |
| GADICKE ANSBERT Director | 2021-08-30 | Sale | −4,285 | $29.30 | $125,551 | 260,152 | D |
| GADICKE ANSBERT Director | 2021-08-30 | Sale | −31,001 | $29.30 | $908,329 | 7,761,125 | I |
| Open-market sales · 50,489 sh · avg $29.24 · $1,476,135 | |||||||
Loading xslF345X03/doc4.xml…